Related Experiment Videos

The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis

B Finkel-Jimenez1, M Wüthrich, T Brandhorst

  • 1Department of Pediatrics, Comprehensive Cancer Center, University of Wisconsin Medical School, University of Wisconsin Hospital and Clinics, Madison, WI, USA.

Insights

The WI-1 adhesin on Blastomyces dermatitidis inhibits TNF-alpha production by immune cells, promoting lung infections. Boosting TNF-alpha levels controlled fungal infections in mice.

Area of Science:

  • Mycology
  • Immunology
  • Pathogenesis

Background:

  • The WI-1 adhesin is crucial for Blastomyces dermatitidis pathogenicity, primarily by facilitating yeast adherence to lung tissues.
  • Emerging evidence suggests WI-1's role extends beyond adherence, potentially influencing host immune responses.

Purpose of the Study:

  • To investigate if WI-1 modulates host immunity by altering pro-inflammatory cytokine production, specifically TNF-alpha.
  • To elucidate the mechanisms by which WI-1 contributes to pulmonary fungal infections.

Main Methods:

  • Comparing TNF-alpha production in mouse lung fluids infected with wild-type and WI-1 knockout B. dermatitidis.
  • In vitro coculture experiments with lung cells, macrophages, and neutrophils exposed to different yeast strains and purified WI-1.
  • In vivo experiments involving TNF-alpha neutralization and gene therapy to modulate TNF-alpha levels.

Main Results:

  • WI-1 knockout yeast elicited higher TNF-alpha production compared to wild-type yeast in vivo and in vitro.
  • Wild-type yeast inhibited TNF-alpha production, while WI-1 knockout yeast stimulated it; purified WI-1 reversed this effect.
  • In vivo TNF-alpha neutralization worsened infection, whereas increased lung TNF-alpha levels controlled wild-type yeast infections.

Conclusions:

  • The WI-1 adhesin actively suppresses phagocyte TNF-alpha production, thereby facilitating the progression of Blastomyces dermatitidis pulmonary infections.
  • Targeting TNF-alpha represents a potential therapeutic strategy for managing B. dermatitidis infections.

Related Concept Videos